Simplex Trading
CVS icon

Simplex Trading’s CVS Health CVS Stock Holding History

Simplex Trading’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$27.5M Sell
383,000
-378,400
-50% -$29.1M 0.02% 348
2025
Q4 		$60.4M Sell
761,400
-93,800
-11% -$7.39M 0.03% 244
2025
Q3 		$64.5M Sell
855,200
-469,900
-35% -$32.2M 0.03% 288
2025
Q2 		$91.4M Sell
1,325,100
-1,007,700
-43% -$66.1M 0.05% 173
2025
Q1 		$158M Sell
2,332,800
-654,200
-22% -$39.1M 0.1% 94
2024
Q4 		$134M Buy
2,987,000
+1,590,000
+114% +$89.2M 0.08% 132
2024
Q3 		$87.8M Sell
1,397,000
-333,300
-19% -$19.4M 0.05% 188
2024
Q2 		$102M Buy
1,730,300
+695,100
+67% +$43.5M 0.06% 153
2024
Q1 		$82.6M Buy
1,035,200
+213,100
+26% +$16.3M 0.05% 218
2023
Q4 		$64.9M Sell
822,100
-217,700
-21% -$15.5M 0.04% 264
2023
Q3 		$72.6M Sell
1,039,800
-199,500
-16% -$14.1M 0.06% 197
2023
Q2 		$85.7M Buy
1,239,300
+240,000
+24% +$17.1M 0.07% 169
2023
Q1 		$74.3M Buy
999,300
+537,100
+116% +$45M 0.07% 207
2022
Q4 		$43.1M Buy
462,200
+51,600
+13% +$4.98M 0.05% 305
2022
Q3 		$39.2M Buy
410,600
+22,900
+6% +$2.27M 0.04% 317
2022
Q2 		$35.9M Sell
387,700
-500,200
-56% -$48.8M 0.04% 328
2022
Q1 		$89.9M Buy
887,900
+96,100
+12% +$10.1M 0.08% 174
2021
Q4 		$81.7M Buy
791,800
+116,800
+17% +$10.8M 0.08% 185
2021
Q3 		$55.5M Buy
675,000
+14,600
+2% +$1.22M 0.05% 229
2021
Q2 		$55.1M Buy
660,400
+655,929
+14,671% +$53.7M 0.05% 225
2021
Q1 		$33.6M Buy
+4,471
New +$326K 0.06% 187
2020
Q4 		– Sell
-7,102
Closed -$41.5M – 8448
2020
Q3 		$41.5M Buy
7,102
+2,060
+41% +$128K 0.06% 189
2020
Q2 		$32.8M Sell
5,042
-3,976
-44% -$250K 0.05% 206
2020
Q1 		$53.5M Buy
9,018
+647
+8% +$43.2K 0.09% 104
2019
Q4 		$62.2M Sell
8,371
-1,146
-12% -$80.5K 0.14% 84
2019
Q3 		$60M Buy
9,517
+3,590
+61% +$213K 0.17% 75
2019
Q2 		$32.3M Sell
5,927
-1,923
-24% -$104K 0.09% 140
2019
Q1 		$42.3M Buy
7,850
+2,884
+58% +$178K 0.12% 113
2018
Q4 		$32.5M Buy
4,966
+688
+16% +$51.4K 0.1% 129
2018
Q3 		$33.7M Buy
4,278
+923
+28% +$66K 0.11% 128
2018
Q2 		$21.6M Buy
3,355
+1,716
+105% +$113K 0.08% 165
2018
Q1 		$171K Sell
1,639
-710
-30% -$50.9K 0.01% 1347
2017
Q4 		$238K Sell
2,349
-225
-9% -$16.4K 0.01% 1153
2017
Q3 		$433K Sell
2,574
-786
-23% -$62.2K 0.02% 747
2017
Q2 		$569K Sell
3,360
-82
-2% -$6.47K 0.02% 582
2017
Q1 		$332K Buy
3,442
+111
+3% +$8.86K 0.01% 912
2016
Q4 		$378K Buy
3,331
+699
+27% +$56.6K 0.02% 679
2016
Q3 		$289K Buy
2,632
+335
+15% +$31.6K 0.02% 799
2016
Q2 		$757K Sell
2,297
-307
-12% -$30.6K 0.05% 371
2016
Q1 		$1.42M Buy
2,604
+620
+31% +$60.3K 0.11% 166
2015
Q4 		$727K Sell
1,984
-470
-19% -$46K 0.06% 297
2015
Q3 		$593K Buy
2,454
+1,559
+174% +$164K 0.04% 390
2015
Q2 		$611K Sell
895
-204
-19% -$20.8K 0.05% 342
2015
Q1 		$730K Buy
1,099
+678
+161% +$68.6K 0.08% 232
2014
Q4 		$589K Buy
+421
New +$37.1K 0.07% 235

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Simplex Trading's CVS Position: Q1 2026 in Review

Simplex Trading increased its CVS Health (CVS) stake by 61% in Q1 2026, buying an estimated $2.16M and bringing the position to 74,158 shares worth $5.33M. The position accounts for ﹤0.01% of the portfolio, ranked #1073.

Simplex Trading first reported a position in CVS in Q1 2016 and has held it in 30 quarters since. The position peaked at $33.8M in Q3 2024. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Simplex Trading held 74,158 shares of CVS Health worth $5.33M as of Q1 2026.
  • Simplex Trading bought 27,987 CVS Health shares in Q1 2026, an estimated $2.16M.
  • CVS Health made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #1073 holding.
  • Simplex Trading first reported a position in CVS Health in Q1 2016 and has held it in 30 quarters since.
  • Simplex Trading's CVS Health position peaked at $33.8M in Q3 2024.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.